Toxicology studies are inherently expensive due to the complexity and depth of analyses required. These studies often involve multiple phases, including in vitro, in vivo, and clinical trials. Each phase necessitates sophisticated equipment, highly skilled personnel, and extensive time. Moreover, ensuring regulatory compliance with agencies like the FDA or EPA adds an additional layer of cost. The need for ethical considerations, such as humane treatment of test animals, further escalates the financial burden.
